1 |
Elenga N, Adeline A, Balcaen J, Vaz T, Calvez M, Terraz A, et al. Pregnancy in sickle cell disease is a very high-risk situation: an observational study. Obstet Gynecol Int. 2016; 2016: 9069054.
|
2 |
Ataga KI, Derebail VK, Archer DR. The glomerulopathy of sickle cell disease. Am J Hematol. 2014; 89(9): 907-14.
doi: 10.1002/ajh.23762
pmid: 24840607
|
3 |
Rogers DT, Molokie R. Sickle cell disease in pregnancy. Obstet Gynecol Clin North Am. 2010; 37(2): 223-37.
doi: 10.1016/j.ogc.2010.02.015
|
4 |
Prophet J, Kelly K, Domingo J, Ayeni H, Mekouguem XPD, Dockery B, et al. Severe pre-eclampsia among pregnant women with sickle cell disease and HIV. Pregnancy Hypertens. 2018; 11: 87-91.
doi: S2210-7789(17)30357-4
pmid: 29523281
|
5 |
Kuo K, Caughey AB. Contemporary outcomes of sickle cell disease in pregnancy. Am J Obstet Gynecol. 2016; 215(4): 505.e1-5.
doi: 10.1016/j.ajog.2016.05.032
|
6 |
Boafor TK, Olayemi E, Galadanci N, Hayfron-Benjamin C, Dei-Adomakoh Y, Segbefia C, et al. Pregnancy outcomes in women with sickle-cell disease in low and high income countries: a systematic review and meta-analysis. BJOG. 2016; 123(5): 691-8.
doi: 10.1111/1471-0528.13786
|
7 |
Yee MM, Jabbar SF, Osunkwo I, Clement L, Lane PA, Eckman JR, et al. Chronic kidney disease and albuminuria in children with sickle cell disease. Clin J Am Soc Nephrol. 2011; 6(11): 2628-33.
doi: 10.2215/CJN.01600211
|
8 |
Nath KA, Hebbel RP. Sickle cell disease: renal manifestations and mechanisms. Nat Rev Nephrol. 2015; 11(3): 161-71.
doi: 10.1038/nrneph.2015.8
pmid: 25668001
|
9 |
Darbari DS, Wang ZY, Kwak M, Hildesheim M, Nichols J, Allen D, et al. Severe painful vaso-occlusive crises and mortality in a contemporary adult sickle cell anemia cohort study. PLoS One. 2013; 8(11): e79923.
doi: 10.1371/journal.pone.0079923
|
10 |
Gladwin MT, Barst RJ, Gibbs JS, Hildesheim M, Sachdev V, Nouraie M, et al. Risk factors for death in 632 patients with sickle cell disease in the United States and United Kingdom. PLoS One. 2014; 9(7): e99489.
doi: 10.1371/journal.pone.0099489
|
11 |
Elmariah H, Garrett ME, De Castro LM, Jonassaint JC, Ataga KI, Eckman JR, et al. Factors associated with survival in a contemporary adult sickle cell disease cohort. Am J Hematol. 2014; 89(5): 530-5.
doi: 10.1002/ajh.23683
pmid: 24478166
|
12 |
Villers MS, Jamison MG, De Castro LM, James AH. Morbidity associated with sickle cell disease in pregnancy. Am J Obstet Gynecol. 2008; 199(2): 125. e1-5.
|
13 |
Leeman L, Fontaine P. Hypertensive disorders of pregnancy. Am Fam Physician. 2008; 78(1): 93-100.
pmid: 18649616
|
14 |
Loisel DA, Billstrand C, Murray K, Patterson K, Chaiworapongsa T, Romero R, et al. The maternal HLA-G 1597ΔC null mutation is associated with increased risk of pre-eclampsia and reduced HLA-G expression during pregnancy in African-American women. Mol Hum Reprod. 2013; 19(3): 144-52.
doi: 10.1093/molehr/gas041
pmid: 23002110
|
15 |
Reidy KJ, Hjorten RC, Simpson CL, Rosenberg AZ, Rosenblum SD, Kovesdy CP, et al. Fetal-not maternal-APOL1 genotype associated with risk for preeclampsia in those with African ancestry. Am J Hum Genet. 2018; 103(3): 367-76.
doi: S0002-9297(18)30268-4
pmid: 30173819
|
16 |
Too GT, Hill JB. Hypertensive crisis during pregnancy and postpartum period. Semin Perinatol. 2013; 37(4): 280-7.
doi: 10.1053/j.semperi.2013.04.007
pmid: 23916027
|
17 |
Samuel A, Lin C, Parviainen K, Jeyabalan A. Expectant management of preeclampsia superimposed on chronic hypertension. J Matern Fetal Neonatal Med. 2011; 24(7): 907-11.
doi: 10.3109/14767058.2010.535874
pmid: 21142774
|
18 |
Yu CKH, Stasiowska E, Stephens A, Awogbade M, Davies A. Outcome of pregnancy in sickle cell disease patients attending a combined obstetric and haematology clinic. J Obstet Gynaecol. 2009; 29(6): 512-6.
doi: 10.1080/01443610903003175
pmid: 19697199
|